Changes in levels of selected incretins and appetite-controlling hormones following surgical treatment for morbid obesity

Wideochirurgia I Inne Techniki Maloinwazyjne

Volumn 10, Issue 3, 2015, Pages 458-465

  Major, Piotr ^a   Matłok, Maciej ^a   Pędziwiatr, Michał ^a   Migaczewski, Marcin ^a   Zub Pokrowiecka, Anna ^a   Radkowiak, Dorota ^a   Winiarski, Marek ^a   Zychowicz, Anna ^a   Fedak, Danuta ^a   Budzyński, Andrzej ^a  

^a JAGIELLONIAN UNIVERSITY MEDICAL COLLEGE   (Poland)

Author keywords

Bariatric surgery; Ghrelin; Glucagon like peptide 1; Laparoscopic sleeve gastrectomy (LSG); Leptin; Roux en Y gastric bypass (RYGB)

Indexed keywords

GHRELIN; GLUCAGON LIKE PEPTIDE 1; INCRETIN; LEPTIN; PEPTIDE YY;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; FEMALE; FOLLOW UP; GHRELIN BLOOD LEVEL; GLUCAGON LIKE PEPTIDE 1 BLOOD LEVEL; HORMONE BLOOD LEVEL; HORMONE RELEASE; HUMAN; HYPERTENSION; INTERMETHOD COMPARISON; LAPAROSCOPIC SLEEVE GASTRECTOMY; LAPAROSCOPIC SURGERY; LEPTIN BLOOD LEVEL; MALE; METABOLISM; MORBID OBESITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PEPTIDE YY BLOOD LEVEL; POSTOPERATIVE PERIOD; PROSPECTIVE STUDY; ROUX Y ANASTOMOSIS; SLEEVE GASTRECTOMY; WEIGHT REDUCTION;

EID: 84943142913     PISSN: 18954588     EISSN: 22990054     Source Type: Journal    
DOI: 10.5114/wiitm.2015.54003     Document Type: Article

References (16)

1. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med 2005; 142: 547-59.
2. Buchwald H, Estok R, Fahrbach K, et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. Surgery 2007; 142: 621-32; discussion 632-5.
3. Hameed S, Dhillo WS, Bloom SR. Gut hormones and appetite control. Oral Dis 2009; 15: 18-26.
4. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-37.
5. Pournaras DJ, Le Roux CW. The effect of bariatric surgery on gut hormones that alter appetite. Diabetes Metab 2009; 35: 508-12.
6. Pournaras DJ, le Roux CW. Obesity, gut hormones, and bariatric surgery. World J Surg 2009; 33: 1983-8.
7. Szewczyk T, Janczak P, Janiak A, et al. Laparoscopic sleeve gastrectomy - 7 years of own experience. Videosurgery Miniinv 2014; 9: 427-35.
8. Lehmann A, Bobowicz M, Lech P, et al. Comparison of percentage excess weight loss after laparoscopic sleeve gastrectomy and laparoscopic adjustable gastric banding. Videosurgery Miniinv 2014; 9: 351-6.
9. Buzga M, Zavadilová V, Holéczy P, et al. Dietary intake and ghrelin and leptin changes after sleeve gastrectomy. Videosurgery Miniinv 2014; 9: 554-61.
10. Kasalicky M, Dolezel R, Vernerova E, Haluzik M. Laparoscopic sleeve gastrectomy without over-sewing of the staple line is effective and safe. Videosurgery Miniinv 2014; 9: 46-52.
11. Nannipieri M, Baldi S, Mari A, et al. Roux-en-Y gastric bypass and sleeve gastrectomy: mechanisms of diabetes remission and role of gut hormones. J Clin Endocrinol Metab 2013; 98: 4391-9.
12. Buchwald H, Dorman RB, Rasmus NF, et al. Effects on GLP-1, PYY, and leptin by direct stimulation of terminal ileum and cecum in humans: implications for ileal transposition. Surg Obes Relat Dis 2014; 10: 780-6.
13. Terra X, Auguet T, Guiu-Jurado E, et al. Long-term changes in leptin, chemerin and ghrelin levels following different bariatric surgery procedures: Roux-en-Y gastric bypass and sleeve gastrectomy. Obes Surg 2013; 23: 1790-8.
14. Morinigo R, Lacy AM, Casamitjana R, et al. GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects. Obes Surg 2006; 16: 1594-601.
15. Reinehr T, Roth CL, Schernthaner GH, et al. Peptide YY and glucagon- like peptide-1 in morbidly obese patients before and after surgically induced weight loss. Obes Surg 2007; 17: 1571-7.
16. Yousseif A, Emmanuel J, Karra E, et al. Differential effects of laparoscopic sleeve gastrectomy and laparoscopic gastric bypass on appetite, circulating acyl-ghrelin, peptide YY3-36 and active GLP-1 levels in non-diabetic humans. Obes Surg 2014; 24: 241-52.